When DM patients were excluded from the control group, serum irisin levels were still significantly higher in the NAFLD group than in the control group (63.4±32.6 vs. 43.0±29.9, p<0.001). The gene discussed is FNDC5; the disease is metabolic dysfunction-associated steatotic liver disease.